Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
1,986,386
-
Share change
-
-193,426
-
Total reported value
-
$3,875,000
-
Price per share
-
$1.95
-
Number of holders
-
10
-
Value change
-
-$379,906
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q2 2018
As of 30 Jun 2018,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,986,386 shares.
The largest 10 holders included
Hikari Power Ltd, NEA Management Company, LLC, Vivo Capital, LLC, Endurant Capital Management LP, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, Virtu Financial LLC, Parallax Volatility Advisers, L.P., and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.